1-20 of 25
Pierre Laurent-Puig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine

Sophie Mouillet-Richard, Antoine Cazelles, Marine Sroussi, Claire Gallois, Julien Taieb, Pierre Laurent-Puig
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (11): 2351–2358.
https://doi.org/10.1158/1078-0432.CCR-23-3964
Published: 03 June 2024
View article titled, Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine
Open the PDF for Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine in another window
Journal Articles

Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors

Claire Gallois, Matteo Landi, Julien Taieb, Marine Sroussi, Bahar Saberzadeh-Ardestani, Antoine Cazelles, Sara Lonardi, Francesca Bergamo, Rossana Intini, Giulia Maddalena, Filippo Pietrantonio, Francesca Corti, Margherita Ambrosini, Antonia Martinetti, Marco Maria Germani, Chiara Boccaccio, Guglielmo Vetere, Sophie Mouillet-Richard, Aurélien de Reynies, Frank A. Sinicrope, Chiara Cremolini, Pierre Laurent-Puig
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18): 3771–3778.
https://doi.org/10.1158/1078-0432.CCR-22-3964
Published: 15 September 2023
View article titled, Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors
Open the PDF for Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors in another window
Includes: Supplementary data
Journal Articles

Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components

Shulin Zhao, Rémy Nicolle, Jérémy Augustin, Magali Svrcek, Louis de Mestier, Delphine Le Corre, Daniel Pietrasz, Olivier Caliez, Jérôme Cros, Pierre Laurent-Puig, Jean-Baptiste Bachet
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6491–6499.
https://doi.org/10.1158/1078-0432.CCR-21-1907
Published: 01 December 2021
View article titled, Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components
Open the PDF for Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components in another window
Includes: Supplementary data
Journal Articles

Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial

Julien Taieb, Valérie Taly, Julie Henriques, Camille Bourreau, Laurent Mineur, Jaafar Bennouna, Jérôme Desrame, Christophe Louvet, Céline Lepere, May Mabro, Joëlle Egreteau, Olivier Bouche, Claire Mulot, Katia Hormigos, Kariman Chaba, Thibault Mazard, Aimery de Gramont, Dewi Vernerey, Thierry André, Pierre Laurent-Puig
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (20): 5638–5646.
https://doi.org/10.1158/1078-0432.CCR-21-0271
Published: 15 October 2021
View article titled, Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a <em>Post Hoc</em> Analysis of the PRODIGE-GERCOR IDEA-France Trial
Open the PDF for Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a <em>Post Hoc</em> Analysis of the PRODIGE-GERCOR IDEA-France Trial in another window
Includes: Supplementary data
Journal Articles

Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer

Laetitia Marisa, Yuna Blum, Julien Taieb, Mira Ayadi, Camilla Pilati, Karine Le Malicot, Côme Lepage, Ramon Salazar, Daniela Aust, Alex Duval, Hélène Blons, Valérie Taly, David Gentien, Audrey Rapinat, Janick Selves, Sophie Mouillet-Richard, Valérie Boige, Jean-François Emile, Aurélien de Reyniès, Pierre Laurent-Puig
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (17): 4768–4780.
https://doi.org/10.1158/1078-0432.CCR-21-0529
Published: 01 September 2021
View article titled, Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer
Open the PDF for Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma

Jean-Baptiste Bachet, Hélène Blons, Pascal Hammel, Iman El Hariry, Fabienne Portales, Laurent Mineur, Jean-Philippe Metges, Claire Mulot, Camille Bourreau, Jason Cain, Jérôme Cros, Pierre Laurent-Puig
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (19): 5208–5216.
https://doi.org/10.1158/1078-0432.CCR-20-0950
Published: 01 October 2020
View article titled, Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma
Open the PDF for Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer

Pierre Laurent-Puig, Marie-Lise Grisoni, Volker Heinemann, François Liebaert, Daniel Neureiter, Andreas Jung, François Montestruc, Yann Gaston-Mathe, Raphaële Thiébaut, Sebastian Stintzing
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (1): 134–141.
https://doi.org/10.1158/1078-0432.CCR-18-1324
Published: 03 January 2019
View article titled, Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in <em>RAS</em> Wild-Type Metastatic Colorectal Cancer
Open the PDF for Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in <em>RAS</em> Wild-Type Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

Jérôme Biton, Audrey Mansuet-Lupo, Nicolas Pécuchet, Marco Alifano, Hanane Ouakrim, Jennifer Arrondeau, Pascaline Boudou-Rouquette, François Goldwasser, Karen Leroy, Jeremy Goc, Marie Wislez, Claire Germain, Pierre Laurent-Puig, Marie-Caroline Dieu-Nosjean, Isabelle Cremer, Ronald Herbst, Hélène Blons, Diane Damotte
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (22): 5710–5723.
https://doi.org/10.1158/1078-0432.CCR-18-0163
Published: 15 November 2018
View article titled, <em>TP53, STK11</em>, and <em>EGFR</em> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma
Open the PDF for <em>TP53, STK11</em>, and <em>EGFR</em> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy

Claire Gallois, Julien Taieb, Delphine Le Corre, Karine Le Malicot, Josep Tabernero, Claire Mulot, Jean-François Seitz, Thomas Aparicio, Gunnar Folprecht, Côme Lepage, Enrico Mini, Jean-Luc Van Laethem, Jean-François Emile, Pierre Laurent-Puig
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (19): 4745–4753.
https://doi.org/10.1158/1078-0432.CCR-18-0866
Published: 01 October 2018
View article titled, Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy
Open the PDF for Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

Fanny Garlan, Pierre Laurent-Puig, David Sefrioui, Nathalie Siauve, Audrey Didelot, Nasrin Sarafan-Vasseur, Pierre Michel, Geraldine Perkins, Claire Mulot, Hélène Blons, Julien Taieb, Frederic Di Fiore, Valerie Taly, Aziz Zaanan
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (18): 5416–5425.
https://doi.org/10.1158/1078-0432.CCR-16-3155
Published: 14 September 2017
View article titled, Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)
Open the PDF for Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) in another window
Includes: Supplementary data
Journal Articles

A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer

Manuela Salvucci, Maximilian L. Würstle, Clare Morgan, Sarah Curry, Mattia Cremona, Andreas U. Lindner, Orna Bacon, Alexa J. Resler, Áine C. Murphy, Robert O'Byrne, Lorna Flanagan, Sonali Dasgupta, Nadege Rice, Camilla Pilati, Elisabeth Zink, Lisa M. Schöller, Sinead Toomey, Mark Lawler, Patrick G. Johnston, Richard Wilson, Sophie Camilleri-Broët, Manuel Salto-Tellez, Deborah A. McNamara, Elaine W. Kay, Pierre Laurent-Puig, Sandra Van Schaeybroeck, Bryan T. Hennessy, Daniel B. Longley, Markus Rehm, Jochen H.M. Prehn
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (5): 1200–1212.
https://doi.org/10.1158/1078-0432.CCR-16-1084
Published: 28 February 2017
View article titled, A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
Open the PDF for A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker

Daniel Pietrasz, Nicolas Pécuchet, Fanny Garlan, Audrey Didelot, Olivier Dubreuil, Solène Doat, Francoise Imbert-Bismut, Mehdi Karoui, Jean-Christophe Vaillant, Valérie Taly, Pierre Laurent-Puig, Jean-Baptiste Bachet
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1): 116–123.
https://doi.org/10.1158/1078-0432.CCR-16-0806
Published: 02 January 2017
View article titled, Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
Open the PDF for Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker in another window
Includes: Supplementary data
Journal Articles

Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

Etienne Becht, Aurélien de Reyniès, Nicolas A. Giraldo, Camilla Pilati, Bénédicte Buttard, Laetitia Lacroix, Janick Selves, Catherine Sautès-Fridman, Pierre Laurent-Puig, Wolf Herman Fridman
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16): 4057–4066.
https://doi.org/10.1158/1078-0432.CCR-15-2879
Published: 14 August 2016
View article titled, Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
Open the PDF for Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Clinical Relevance of KRAS-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy

Pierre Laurent-Puig, Deniz Pekin, Corinne Normand, Steve K. Kotsopoulos, Philippe Nizard, Karla Perez-Toralla, Rachel Rowell, Jeff Olson, Preethi Srinivasan, Delphine Le Corre, Thevy Hor, Zakaria El Harrak, Xinyu Li, Darren R. Link, Olivier Bouché, Jean-François Emile, Bruno Landi, Valérie Boige, J. Brian Hutchison, Valerie Taly
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1087–1097.
https://doi.org/10.1158/1078-0432.CCR-14-0983
Published: 01 March 2015
View article titled, Clinical Relevance of <em>KRAS</em>-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy
Open the PDF for Clinical Relevance of <em>KRAS</em>-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy in another window
Includes: Supplementary data
Journal Articles

A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy

Zenia Saridaki, Joanne B. Weidhaas, Heinz-Josef Lenz, Pierre Laurent-Puig, Bart Jacobs, Jef De Schutter, Wendy De Roock, David W. Salzman, Wu Zhang, Dongyun Yang, Camilla Pilati, Olivier Bouché, Hubert Piessevaux, Sabine Tejpar
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (17): 4499–4510.
https://doi.org/10.1158/1078-0432.CCR-14-0348
Published: 01 September 2014
View article titled, A <em>let-7</em> microRNA-Binding Site Polymorphism in <em>KRAS</em> Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy
Open the PDF for A <em>let-7</em> microRNA-Binding Site Polymorphism in <em>KRAS</em> Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy in another window
Includes: Supplementary data
Journal Articles

Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy

Gilles Manceau, Sandrine Imbeaud, Raphaële Thiébaut, François Liébaert, Karine Fontaine, Francis Rousseau, Bérengère Génin, Delphine Le Corre, Audrey Didelot, Marc Vincent, Jean-Baptiste Bachet, Benoist Chibaudel, Olivier Bouché, Bruno Landi, Frédéric Bibeau, Karen Leroy, Frédérique Penault-Llorca, Jean-Luc Van Laethem, Pieter Demetter, Sabine Tejpar, Simona Rossi, Neda Mosakhani, Pia Österlund, Raija Ristamäki, Virinder Sarhadi, Sakari Knuutila, Valérie Boige, Thierry André, Pierre Laurent-Puig
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (12): 3338–3347.
https://doi.org/10.1158/1078-0432.CCR-13-2750
Published: 12 June 2014
View article titled, Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Open the PDF for Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy in another window
Includes: Supplementary data
Journal Articles

Modeling RAS Phenotype in Colorectal Cancer Uncovers Novel Molecular Traits of RAS Dependency and Improves Prediction of Response to Targeted Agents in Patients

Justin Guinney, Charles Ferté, Jonathan Dry, Robert McEwen, Gilles Manceau, KJ Kao, Kai-Ming Chang, Claus Bendtsen, Kevin Hudson, Erich Huang, Brian Dougherty, Michel Ducreux, Jean-Charles Soria, Stephen Friend, Jonathan Derry, Pierre Laurent-Puig
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (1): 265–272.
https://doi.org/10.1158/1078-0432.CCR-13-1943
Published: 05 January 2014
View article titled, Modeling RAS Phenotype in Colorectal Cancer Uncovers Novel Molecular Traits of RAS Dependency and Improves Prediction of Response to Targeted Agents in Patients
Open the PDF for Modeling RAS Phenotype in Colorectal Cancer Uncovers Novel Molecular Traits of RAS Dependency and Improves Prediction of Response to Targeted Agents in Patients in another window
Includes: Supplementary data
Journal Articles

Colon Cancer Mutation: Prognosis/Prediction–Letter

Aziz Zaanan, Franck Bonnetain, Franck A. Sinicrope, Pierre Laurent-Puig, Julien Taïeb
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (5): 1300.
https://doi.org/10.1158/1078-0432.CCR-12-3765
Published: 03 March 2013
View article titled, Colon Cancer Mutation: Prognosis/Prediction–Letter
Open the PDF for Colon Cancer Mutation: Prognosis/Prediction–Letter in another window
Journal Articles

Mutations and Response to Epidermal Growth Factor Receptor Inhibitors

Pierre Laurent-Puig, Astrid Lievre, Hélène Blons
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1133–1139.
https://doi.org/10.1158/1078-0432.CCR-08-0905
Published: 19 February 2009
View article titled, Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
Open the PDF for Mutations and Response to Epidermal Growth Factor Receptor Inhibitors in another window
Journal Articles

K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy

Marie-Christine Etienne-Grimaldi, Jean-Louis Formento, Mireille Francoual, Eric François, Patricia Formento, Nicole Renée, Pierre Laurent-Puig, Maurice Chazal, Daniel Benchimol, Jean-Robert Delpero, Christian Letoublon, Denis Pezet, Jean-François Seitz, Gérard Milano
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4830–4835.
https://doi.org/10.1158/1078-0432.CCR-07-4906
Published: 01 August 2008
View article titled, K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy
Open the PDF for K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy in another window